PPH

VanEck Pharmaceutical ETF
*Unless otherwise stated, data provided by FactSet.

PPH Fund Description

PPH tracks a market-cap-weighted index of 25 of the largest global pharmaceutical firms.

PPH Factset Analytics Insight

PPH provides exposure to the largest, US-listed multinational pharmaceutical giants in the world. The fund holds just 25 securities, including big weights in household names. Like the underlying pharmaceutical market, PPH is top heavy and has to reweight its big holdings to accommodate RIC diversification requirements, capping a single issuer to 20%. Still, it captures the space well, even after excluding Asia entirely. Overall, PPH is a great option for investors seeking exposure to big, multinational pharma companies. The index is reviewed on a semi-annual basis.

PPH MSCI ESG Analytics Insight

VanEck Pharmaceutical ETF has an MSCI ESG Fund Rating of A based on a score of 6.74 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. VanEck Pharmaceutical ETF ranks in the 44th percentile within its peer group and in the 84th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

PPH MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 01/20/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
PPH 1.12% 3.70% -1.46% 9.31% 11.31% 9.80% 9.71%
PPH (NAV) 0.91% 2.08% -1.90% 9.15% 11.09% 9.81% 9.75%
Thomson Reuters Global Pharmaceuticals -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

PPH Summary Data

VanEck
02/01/00
Open-Ended Fund
0.35%
$389.71M
$3.34M
0.05%
N/A

PPH Portfolio Data

$131.47B
57.08
3.22
1.65%
04/01/22
25

PPH Index Data

MVIS U.S. Listed Pharmaceutical 25 Index
Market Cap
Market Cap
Thomson Reuters Global Pharmaceuticals

PPH Portfolio Management

0.35%
0.33%
0.44%
-0.01%

PPH Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

PPH Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

PPH Factset Analytics Block Liquidity

As of 01/21/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PPH. PPH is rated a 5 out of 5.

PPH Tradability

44,182
$3.34M
32,452
$2.41M
0.05%
$0.03
0.02%
0.26% / -0.22%
None
92.00%
50,000
0.65
0.01%
0.12%
572
$75.49
5

PPH Sector/Industry Breakdown


PPH
Segment Benchmark
82.82%
97.78%
4.99%
0.00%
4.96%
0.01%
0.57%
0.05%

PPH Top 10 Holdings[View All]

AbbVie, Inc. 5.35%
Pfizer Inc. 5.02%
51.68%

PPH Countries


PPH
Segment Benchmark
66.88%
50.40%
9.99%
6.86%
5.66%
2.97%
5.09%
3.15%
4.84%
14.40%
3.67%
7.71%
3.30%
0.25%
0.57%
--
--
0.42%
--
0.12%

PPH Regions


PPH
Segment Benchmark
66.88%
50.62%
26.15%
31.15%
3.67%
17.73%
3.30%
0.43%
--
0.08%

PPH Economic Development


PPH
Segment Benchmark
100.00%
97.48%
--
2.52%

PPH Performance Statistics

0.74
1.03
1.06
0.98
0.38%
Thomson Reuters Global Pharmaceuticals

PPH MSCI ESG Ratings

6.74 / 10
83.84
44.27
--
--
25.71

PPH Benchmark Comparison Holdings

25
412
19
53.46%

PPH Benchmark Comparison Summary


PPH
Segment Benchmark
25
412
$131.47B
$183.06B
57.08
31.38
3.22
4.45
2.38%
2.51%
High
High

PPH Benchmark Comparison Market Cap Size


PPH
Segment Benchmark
86.75%
88.63%
12.69%
7.23%
0.57%
2.99%
0.00%
1.12%